PHILADELPHIA--(BUSINESS WIRE)--BioAdvance announced that during the past 12 months it added nine new companies and technologies to its portfolio and made follow-on investments in six of its existing ...
PHILADELPHIA--(BUSINESS WIRE)--BioAdvance announced that during its fiscal year that will end on June 30, 2015, its life sciences portfolio companies attracted $85 million of capital from private ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results